TerrAscend to Participate in the ATB Capital Markets 2024 Life Sciences Institutional Investor Conference on September 18th in NYC

Rhea-AI Summary

TerrAscend Corp. (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, has announced its participation in the ATB Capital Markets 2024 Life Sciences Institutional Investor Conference on September 18, 2024, in New York City. Key highlights include:

• Jason Wild, Executive Chairman, will join a panel discussion on cannabis reform's impact on valuations and investor engagement
• The panel is scheduled for September 18th at 8:00 AM ET
• Management team, including Wild, CEO Ziad Ghanem, and CFO Keith Stauffer, will host one-on-one meetings during the conference

This event provides an opportunity for TerrAscend to engage with institutional investors and discuss the evolving cannabis industry landscape.

TORONTO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, today announced that its executive management team will participate in the ATB Capital Markets 2024 Life Sciences Institutional Investor Conference being held on September 18, 2024 in New York City.

Jason Wild, Executive Chairman, will participate in a panel discussion, “Regulatory Ripples, Market Impacts: How Cannabis Reform Will Impact Valuations and Investor Engagement”, alongside Dan Ahrens, Chief Operating Officer of Advisor Shares and moderated by Frederico Gomes, Director of Institutional Research in Life Sciences at ATB Capital markets, on Wednesday, September 18th at 8:00 AM ET.

Management including Mr. Wild, Ziad Ghanem, Chief Executive Officer, and Keith Stauffer, Chief Financial Officer, will host one-on-one meetings throughout the conference. Please reach out to your conference representative or email IR@TerrAscend.com.

About TerrAscend
TerrAscend is a leading TSX-listed cannabis company with interests across the North American cannabis sector, including vertically integrated operations in Pennsylvania, New Jersey, Maryland, Michigan and California through TerrAscend Growth Corp. and retail operations in Canada through TerrAscend Canada Inc. (“TerrAscend”). TerrAscend operates The Apothecarium, Gage and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. TerrAscend’s cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use markets. The Company owns or licenses several synergistic businesses and brands including Gage Cannabis, The Apothecarium, Cookies, Lemonnade, Ilera Healthcare, Kind Tree, Legend, State Flower, Wana, and Valhalla Confections. For more information visit www.terrascend.com.

For more information regarding TerrAscend:
Keith Stauffer
Chief Financial Officer
IR@terrascend.com
855-837-7295

Briana Chester
MATTIO Communications
424-465-4419
terrascend@mattio.com

FAQ

When is TerrAscend (TSNDF) participating in the ATB Capital Markets 2024 Life Sciences Conference?

TerrAscend (TSNDF) is participating in the ATB Capital Markets 2024 Life Sciences Institutional Investor Conference on September 18, 2024, in New York City.

Who from TerrAscend (TSNDF) will be speaking at the ATB Capital Markets conference?

Jason Wild, Executive Chairman of TerrAscend (TSNDF), will participate in a panel discussion at the conference on September 18th at 8:00 AM ET.

What is the topic of the panel discussion featuring TerrAscend's (TSNDF) Executive Chairman?

The panel discussion featuring TerrAscend's (TSNDF) Executive Chairman is titled 'Regulatory Ripples, Market Impacts: How Cannabis Reform Will Impact Valuations and Investor Engagement'.

Will TerrAscend (TSNDF) management be available for meetings during the conference?

Yes, TerrAscend (TSNDF) management, including Jason Wild, CEO Ziad Ghanem, and CFO Keith Stauffer, will host one-on-one meetings throughout the conference.